Solving a longstanding problem in drug delivery

artist's impression of a lipid nanoparticle engineered to switch between a positive and negative charge.

Lipid nanoparticles are great delivery vehicles for mRNA treatments, but their positive charge triggers high levels of inflammation. Now researchers led by Professor Niren Murthy have engineered a new lipid nanoparticle that can switch its charge from positive to negative and may avoid triggering inflammation while still able to deliver mRNA and other nucleic acids.

Read More

Herr Lab and partners receive grant to study biology in time and space

photo of Amy Herr, seated

Our researchers have received a new grant from the Biohub non-profit research organization, looking to advance the field of Spatiotemporal omics – the ability to sample biomolecules at different locations and times to watch disease processes unfold. Amy Herr and her UCSF partners Jennifer Rosenbluth and Amrita Basu will be studying integrated organoid systems for immunotherapy toxicity.

Read More

Herr wins Weill Neurohub Investigator Award

photo of Amy Herr, seated

A research project on “the protein code of brain aging: from molecules to mechanisms,” by Professor Amy Herr has been selected for a Weill Neurohub Investigator Award. The Investigators program funds top faculty to form cross-campus, interdisciplinary teams to explore, create, and test bold new concepts and technologies.

Read More

Nature provides the answers

close up photo of Messersmith examining a sample of Asparaglue in the lab

An in-depth look at research by Professor Phil Messersmith, who draws on biology to develop cutting-edge materials for medicine. His lab creates adhesives and therapies designed to work with the human body, offering new ways to repair tissues, heal wounds and treat disease.

Read More